RI-MUHC trainee awarded 2022 Vanier Canada Graduate Scholarship
Joan Miguel Romero is investigating T cell−inflammation in pancreatic cancer
RI-MUHC trainee honoured by the American Association for Cancer Research
Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...
LSD, a future antianxiety pill?
A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety
Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai
Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease
Beyond basic research: Coming to grips with a rare disease experience
To honour Rare Disease Day on February 28, an RI-MUHC research trainee shares the perspective he gained as a patient
February 2022 winner of the Relève étoile Jacques-Genest award
Congratulations to Dominique Geoffrion, former doctoral student at the RI-MUHC!
CTN study tests new drug for the first time in people living with HIV
Postdoc Léna Royston aims to understand how cytomegalovirus infection can increase inflammation and cause health issues
RI-MUHC team uncovers new mechanism of inflammation in muscular dystrophy
A new study reveals how signals sent from damaged muscles to the bone marrow can induce long-lasting...
The International Day of Women and Girls in Science – February 11
This day is a welcome reminder that women and girls play a critical role in science and technology communities.
FANCI: a new gene at the origin of some cases of ovarian cancer
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer